# AAV Transfer Plasmid v4.0 - Session Report

**Date:** 2025-12-18
**Status:** ‚úÖ COMPLETE - ssAAV plasmid generated with cloning strategy

---

## Executive Summary

Generated v04 transfer plasmid using a **cloning strategy** instead of stuffer replacement. The EF1a-VP1-polyA cassette is designed to be synthesized and cloned into HindIII/XbaI sites in the backbone.

**Key Changes from v03:**
1. Replaced XbaI (Region 1) with AvrII to avoid conflict with XbaI cloning site
2. Use full 1194 bp EF1Œ± promoter (v03 was truncated to 1172 bp)
3. Preserve both HindIII and XbaI cloning sites in final plasmid

## Important Corrections Made

**Initial v04 (before corrections):**
- ‚ùå EF1Œ± was 1172 bp (missing 22 bp)
- ‚ùå XbaI site was not present in final plasmid

**Corrected v04 (current):**
- ‚úÖ EF1Œ± is 1194 bp (full version from v01)
- ‚úÖ XbaI site preserved at position 3732
- ‚úÖ HindIII site at position 189
- ‚úÖ Proper cloning simulation with both sites regenerated

---

## Motivation for v04

### User Requirements
1. **ITRs must be annotated** - New v02 backbone has ITR128 annotations
2. **Use cloning strategy** - Cassette synthesized and cloned into restriction sites, not stuffer replacement
3. **Cloning sites:** HindIII (upstream) and XbaI (downstream)
4. **Only ssAAV version** needed

### Critical Issue Identified
- **XbaI conflict:** v03 used XbaI as a unique site in VP1 Region 1
- XbaI is also the downstream cloning site in the backbone
- After cloning, XbaI would NOT be unique (one in VP1, one at cloning junction)
- **Solution:** Replace XbaI with AvrII in Region 1

---

## Final Site Selection (v04)

| Region | Enzyme | Type | Mutations | RepCap Position | ssAAV v04 Position |
|--------|--------|------|-----------|----------------|-------------------|
| **1** | **AvrII** | Standard | 1 silent | 2522 | 1522 |
| **2** | **BspEI** | Standard | 2 silent | 2850 | 1850 |
| **3** | **BsmBI** | Type IIS | 1 silent | 3574 | 2574 |
| **4** | **BsrGI** | Standard | 1 silent | 3782 | 2782 |
| **5** | **BmtI** | Standard | 1 silent | 3943 | 2943 |
| **6** | **BstZ17I** | Standard | 1 silent | 4167 | 3167 |

**Total mutations:** 7 silent mutations
**All sites verified:** ‚úÖ Unique in RepCap and ssAAV v04

---

## Mutations Applied

### Region 1: AvrII (NEW - replaces XbaI)
- **Position 2523:** T‚ÜíA | CTT‚ÜíCTA (L‚ÜíL)
- Creates recognition site: CCTAGG
- Only 1 mutation needed (vs 2 for XbaI)
- VP1 amino acid 53

### Region 2: BspEI (kept from v03)
- **Position 2850:** G‚ÜíC | TCG‚ÜíTCC (S‚ÜíS)
- **Position 2853:** T‚ÜíA | GGT‚ÜíGGA (G‚ÜíG)
- VP1 amino acids 162-163

### Region 3: BsmBI (kept from v03)
- **Position 3570:** G‚ÜíT | TCG‚ÜíTCT (S‚ÜíS)
- Type IIS enzyme for Golden Gate assembly
- VP1 amino acid 402

### Regions 4-6: (kept from v03)
- **BsrGI** - Position 3783: C‚ÜíA (VP1 aa 473)
- **BmtI** - Position 3939: C‚ÜíT (VP1 aa 525)
- **BstZ17I** - Position 4164: A‚ÜíT (VP1 aa 600)

---

## Assembly Strategy

### Previous Approach (v01-v03)
```
Replace stuffer region (positions 159-2350) end-to-end with cassette
```

### New Approach (v04)
```
1. Synthesize EF1a-VP1-polyA cassette with HindIII/XbaI flanking sites
2. Digest backbone with HindIII + XbaI
3. Ligate cassette into backbone
4. Result: seamless integration with proper ITR annotations preserved
```

### Cloning Sites in Backbone
- **HindIII:** Position 187 (upstream)
- **XbaI:** Position 2278 (downstream)
- **Removed region:** 187-2278 (2091 bp)
- **Inserted cassette:** 3515 bp (EF1a + VP1 + polyA, without flanking sites)
- **Net change:** +1424 bp

### Backbone Conflict Resolution
- v02 backbone had AvrII at position 2259
- This AvrII was **between** HindIII (187) and XbaI (2278)
- During cloning, this region is removed
- Result: Only the VP1 AvrII remains ‚Üí **unique site** ‚úÖ

---

## Files Generated

### RepCap Plasmid
```
test_data/AAV9-RepCap-NOCAP-v04.gb (7,078 bp)
```
- 7 silent mutations applied to BASE-DRAFT
- All 6 restriction sites verified unique
- AvrII replaces XbaI in Region 1

### Transfer Plasmid
```
test_data/pGS-ssAAV-EF1A-VP1-rBG_v04.gb (6,462 bp)
```
- Assembled using cloning strategy
- EF1Œ± promoter: 1194 bp (full version with intron)
- ITR128 annotations: positions 27-154 and 3758-3885
- Cloning sites preserved: HindIII (189) and XbaI (3732)
- All 6 VP1 sites verified unique
- Only ssAAV version generated

### Analysis Scripts
```
projects/aav_transfer_plasmid/analysis/
‚îú‚îÄ‚îÄ find_avrii_region1.py           # Identify AvrII silent mutation
‚îú‚îÄ‚îÄ generate_v04_repcap.py          # Generate RepCap v04
‚îî‚îÄ‚îÄ assemble_v04_cloning.py         # Assemble transfer plasmid (cloning strategy)
```

---

## Validation Results

### RepCap v04 Verification
```
‚úÖ AvrII      1 site @ position 2522
‚úÖ BspEI      1 site @ position 2850
‚úÖ BsmBI      1 site @ position 3574
‚úÖ BsrGI      1 site @ position 3782
‚úÖ BmtI       1 site @ position 3943
‚úÖ BstZ17I    1 site @ position 4167
```

### Transfer Plasmid v04 Verification

**Cloning sites:**
```
‚úÖ HindIII    1 site @ position 189
‚úÖ XbaI       1 site @ position 3732
```

**VP1 unique sites:**
```
‚úÖ AvrII      1 site @ position 1544
‚úÖ BspEI      1 site @ position 1872
‚úÖ BsmBI      1 site @ position 2596
‚úÖ BsrGI      1 site @ position 2804
‚úÖ BmtI       1 site @ position 2965
‚úÖ BstZ17I    1 site @ position 3189
```

### ITR Annotations
```
‚úÖ ITR128 (left):  27-154
‚úÖ ITR128 (right): 3758-3885
```

### EF1Œ± Promoter
```
‚úÖ Length: 1194 bp (positions 193-1386)
‚úÖ Full version with intron
```

**‚úÖ ALL REQUIREMENTS MET**

---

## Comparison: v03 vs v04

| Aspect | v03 | v04 |
|--------|-----|-----|
| **Region 1 enzyme** | XbaI (2 mutations) | AvrII (1 mutation) ‚úÖ |
| **Assembly strategy** | Stuffer replacement | Cloning into sites ‚úÖ |
| **ITR annotations** | Present but shifted | Annotated correctly ‚úÖ |
| **Backbone** | v01 (no ITRs) | v02 (with ITRs) ‚úÖ |
| **Cloning sites** | N/A | HindIII/XbaI ‚úÖ |
| **EF1Œ± length** | 1172 bp (truncated) | 1194 bp (full) ‚úÖ |
| **XbaI site preserved** | N/A | Yes (position 3732) ‚úÖ |
| **Total mutations** | 8 | 7 ‚úÖ |
| **Plasmid size** | 6,436 bp | 6,462 bp |

---

## Synthesis Strategy

### For Wet Lab Implementation

1. **Synthesize cassette with overhangs:**
   ```
   5'-AAGCTT-[EF1a]-[VP1]-[polyA]-TCTAGA-3'
   ```
   - Length: ~3,527 bp (including HindIII and XbaI sites)
   - 7 silent mutations in VP1 (see mutations table above)

2. **Digest backbone:**
   ```
   pGS-ssAAV-ITR128-Amp-empty_v02.gb
   Digest with: HindIII + XbaI
   ```

3. **Ligate:**
   ```
   Insert cassette between HindIII and XbaI
   Transform into E. coli
   Select on ampicillin
   ```

4. **Verify:**
   ```
   - Sanger sequencing across VP1
   - Restriction digest with all 6 enzymes
   - Confirm single bands for each enzyme
   ```

---

## Applications

### Restriction Sites Enable:

**Standard Cloning:**
- AvrII, BspEI, BsrGI, BmtI, BstZ17I - all widely available

**Golden Gate Assembly:**
- BsmBI (Type IIS) - scarless peptide insertion

**Variable Region Engineering:**
- Sites distributed across VP1 for targeting different VR regions
- Positions: aa 53, 162, 402, 473, 525, 600

**Diagnostic Mapping:**
- Quick QC after cloning
- Verify plasmid identity

---

## Technical Notes

### Why AvrII Over XbaI?

| Criterion | XbaI | AvrII |
|-----------|------|-------|
| Mutations needed | 2 | 1 ‚úÖ |
| Enzyme availability | Very common | Very common |
| Recognition site | TCTAGA | CCTAGG |
| Conflict with cloning | YES ‚ùå | NO ‚úÖ |

**Decision:** AvrII is superior - fewer mutations, no cloning conflicts

### ITR Preservation

The cloning strategy preserves ITR annotations because:
1. ITRs are outside the HindIII-XbaI cloning region
2. Left ITR: 27-154 (before HindIII at 187)
3. Right ITR: 3736-3863 (after inserted cassette)
4. Features after insertion are shifted by +1424 bp

---

## Session Timeline

1. **User request:** Reassemble with ITRs, use cloning strategy, only ssAAV
2. **Identified XbaI conflict** with backbone cloning site
3. **Searched for AvrII alternative** in Region 1
4. **Found AvrII site** requiring only 1 silent mutation (position 2523)
5. **Generated v04 RepCap** with AvrII instead of XbaI
6. **Assembled v04 transfer plasmid** using cloning strategy
7. **Verified all sites unique** and ITRs annotated

---

## Next Steps (If Needed)

1. **Order synthesis** of EF1a-VP1-polyA cassette with v04 mutations
2. **Clone into backbone** using HindIII/XbaI
3. **Sequence verify** all mutations present and no errors
4. **Functional testing** of VP1 capsid assembly
5. **Use BsmBI site** for Golden Gate insertion of VHH nanobodies

---

## Repository State

```
test_data/
‚îú‚îÄ‚îÄ AAV9-RepCap-NOCAP-v04.gb              # v04 RepCap
‚îú‚îÄ‚îÄ pGS-ssAAV-EF1A-VP1-rBG_v04.gb         # v04 transfer plasmid
‚îú‚îÄ‚îÄ pGS-ssAAV-ITR128-Amp-empty_v02.gb     # Backbone with ITRs
‚îî‚îÄ‚îÄ [v03 files preserved for comparison]

projects/aav_transfer_plasmid/
‚îú‚îÄ‚îÄ analysis/
‚îÇ   ‚îú‚îÄ‚îÄ find_avrii_region1.py
‚îÇ   ‚îú‚îÄ‚îÄ generate_v04_repcap.py
‚îÇ   ‚îî‚îÄ‚îÄ assemble_v04_cloning.py
‚îú‚îÄ‚îÄ output/
‚îÇ   ‚îî‚îÄ‚îÄ SESSION_REPORT_v04.md              # This file
‚îî‚îÄ‚îÄ [previous analysis files preserved]
```

---

**Session Status:** ‚úÖ COMPLETE
**Final Design:** v4.0
**Transfer Plasmid:** Generated with cloning strategy
**ITRs:** Annotated
**All Sites:** Unique and verified

**Ready for synthesis and cloning.** üéØ
